332 related articles for article (PubMed ID: 22405700)
21. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China.
Chen JG; Egner PA; Ng D; Jacobson LP; Muñoz A; Zhu YR; Qian GS; Wu F; Yuan JM; Groopman JD; Kensler TW
Cancer Prev Res (Phila); 2013 Oct; 6(10):1038-45. PubMed ID: 23963804
[TBL] [Abstract][Full Text] [Related]
22. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.
Chang MH; You SL; Chen CJ; Liu CJ; Lai MW; Wu TC; Wu SF; Lee CM; Yang SS; Chu HC; Wang TE; Chen BW; Chuang WL; Soon MS; Lin CY; Chiou ST; Kuo HS; Chen DS;
Gastroenterology; 2016 Sep; 151(3):472-480.e1. PubMed ID: 27269245
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei.
Van Rensburg SJ; Cook-Mozaffari P; Van Schalkwyk DJ; Van der Watt JJ; Vincent TJ; Purchase IF
Br J Cancer; 1985 May; 51(5):713-26. PubMed ID: 2986667
[TBL] [Abstract][Full Text] [Related]
25. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
26. The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa.
Turner PC; Sylla A; Diallo MS; Castegnaro JJ; Hall AJ; Wild CP
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S441-8. PubMed ID: 12534775
[TBL] [Abstract][Full Text] [Related]
27. Etiology of hepatocellular carcinoma in Africa.
Olweny CL
IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
[TBL] [Abstract][Full Text] [Related]
28. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
30. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
32. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
[TBL] [Abstract][Full Text] [Related]
33. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
34. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon.
Atsama Amougou M; Marchio A; Bivigou-Mboumba B; Noah Noah D; Banai R; Atangana PJA; Fewou Moundipa P; Pineau P; Njouom R
J Viral Hepat; 2019 Sep; 26(9):1086-1093. PubMed ID: 31106515
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
37. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
38. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of hepatocellular carcinoma.
Yu MC; Yuan JM; Govindarajan S; Ross RK
Can J Gastroenterol; 2000 Sep; 14(8):703-9. PubMed ID: 11185536
[TBL] [Abstract][Full Text] [Related]
40. Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Wang LW; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Lett; 2007 Jul; 252(1):104-14. PubMed ID: 17250958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]